Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020;22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Editor in chief, Dr Audiey Kao, talks with Dr Matthew Wynia about allocation of critical care resources and clinicians' duty to show up to work during public health emergencies.